An overview of gene therapies in the pipeline for ocular disorders

enthalten in: Drugs of the future | 2021

von Ferro Desideri, L. | Vagge, A. | Nicolo, M. | +1

KSI-301. Antibody-biopolymer conjugate targeting VEGF, Treatment of wet age-related macular degeneration, Treatment of diabetic macular edema, Treatment of retinal vein occlusion

enthalten in: Drugs of the future | 2021

von Di Cello, L. | Ferro Desideri, L. | Vagge, A. | +2

Teprotumumab. Anti-insulin-like growth factor 1 receptor (IGF-1R) monoclonal antibody, Treatment of thyroid eye disease

enthalten in: Drugs of the future | 2020

von Ferro Desideri, L. | Vagge, A. | del Noce, C. | +2

Risuteganib. Broad-spectrum integrin inhibitor, Treatment of diabetic macular edema, Treatment of dry age-related macular degeneration

enthalten in: Drugs of the future | 2020

von Ferrio Desideri, L. | Vagge, A. | Testa, V. | +2